Cargando…
APRIL promotes non-small cell lung cancer growth and metastasis by targeting ERK1/2 signaling
Non-small-cell lung cancer (NSCLC) is the major subtype of lung cancer, which is the most common cause of cancer-related mortality in the world. It is a complex disease involving multiple genetic alterations. As a cytokine belonging to the Tumor Necrosis Factor-α (TNF- α) family, the - a proliferati...
Autores principales: | Dou, Hengli, Yan, Zhaohua, Zhang, Meng, Xu, Xiaoxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752521/ https://www.ncbi.nlm.nih.gov/pubmed/29312608 http://dx.doi.org/10.18632/oncotarget.22672 |
Ejemplares similares
-
APRIL, BCMA and TACI proteins are abnormally expressed in non-small cell lung cancer
por: Dou, Hengli, et al.
Publicado: (2016) -
IQGAP3 Promotes EGFR-ERK Signaling and the Growth and Metastasis of Lung Cancer Cells
por: Yang, Ying, et al.
Publicado: (2014) -
Metastasis-associated protein 2 promotes the metastasis of non-small cell lung carcinoma by regulating the ERK/AKT and VEGF signaling pathways
por: Zhang, Bin, et al.
Publicado: (2018) -
Tumor hypoxia enhances non-small cell lung cancer metastasis by selectively promoting macrophage M2 polarization through the activation of ERK signaling
por: Zhang, Jun, et al.
Publicado: (2014) -
Elevated TEFM expression promotes growth and metastasis through activation of ROS/ERK signaling in hepatocellular carcinoma
por: Wan, Lixin, et al.
Publicado: (2021)